Literature DB >> 22671719

The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.

Sjoerd Hak1, Emily Helgesen, Helga H Hektoen, Else Marie Huuse, Peter A Jarzyna, Willem J M Mulder, Olav Haraldseth, Catharina de Lange Davies.   

Abstract

The development and application of nanoparticles as in vivo delivery vehicles for therapeutic and/or diagnostic agents has seen a drastic growth over the last decades. Novel imaging techniques allow real-time in vivo study of nanoparticle accumulation kinetics at the level of the cell and targeted tissue. Successful intravenous application of such nanocarriers requires a hydrophilic particle surface coating, of which polyethylene glycol (PEG) has become the most widely studied and applied. In the current study, the effect of nanoparticle PEG surface density on the targeting efficiency of ligand-functionalized nanoemulsions was investigated. We synthesized 100 nm nanoemulsions with a PEG surface density varying from 5 to 50 mol %. Fluorescent and paramagnetic lipids were included to allow their multimodal detection, while RGD peptides were conjugated to the PEG coating to obtain specificity for the α(v)β(3)-integrin. The development of a unique experimental imaging setup allowed us to study, in real time, nanoparticle accumulation kinetics at (sub)-cellular resolution in tumors that were grown in a window chamber model with confocal microscopy imaging, and at the macroscopic tumor level in subcutaneously grown xenografts with magnetic resonance imaging. Accumulation in the tumor occurred more rapidly for the targeted nanoemulsions than for the nontargeted versions, and the PEG surface density had a strong effect on nanoparticle targeting efficiency. Counterintuitively, yet consistent with the PEG density conformation models, the highest specificity and targeting efficiency was observed at a low PEG surface density.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22671719      PMCID: PMC3389615          DOI: 10.1021/nn301630n

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  43 in total

Review 1.  Multifunctional nanocarriers.

Authors:  Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2006-09-28       Impact factor: 15.470

Review 2.  The multiple faces of caveolae.

Authors:  Robert G Parton; Kai Simons
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 3.  Multimodality nanotracers for cardiovascular applications.

Authors:  Willem J M Mulder; David P Cormode; Sjoerd Hak; Mark E Lobatto; Stephane Silvera; Zahi A Fayad
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08

Review 4.  Imaging of integrin alphavbeta3 expression.

Authors:  Ambros J Beer; Markus Schwaiger
Journal:  Cancer Metastasis Rev       Date:  2008-12       Impact factor: 9.264

Review 5.  Polymer-coated nanoparticles: a universal tool for biolabelling experiments.

Authors:  Feng Zhang; Emma Lees; Faheem Amin; Pilar Rivera Gil; Fang Yang; Paul Mulvaney; Wolfgang J Parak
Journal:  Small       Date:  2011-09-19       Impact factor: 13.281

6.  Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.

Authors:  Sherief Essa; Jean Michel Rabanel; Patrice Hildgen
Journal:  Int J Pharm       Date:  2011-03-31       Impact factor: 5.875

7.  In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.

Authors:  Beena Ashok; Lise Arleth; Rex P Hjelm; Israel Rubinstein; Hayat Onyüksel
Journal:  J Pharm Sci       Date:  2004-10       Impact factor: 3.534

8.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

9.  Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids.

Authors:  Markus Johnsson; Katarina Edwards
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

10.  Investigation of In Vivo Targeting Kinetics of α(v)β(3)-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI.

Authors:  Chase W Kessinger; Osamu Togao; Chalermchai Khemtong; Gang Huang; Masaya Takahashi; Jinming Gao
Journal:  Theranostics       Date:  2011-04-24       Impact factor: 11.556

View more
  53 in total

Review 1.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 2.  New generation of magnetic and luminescent nanoparticles for in vivo real-time imaging.

Authors:  Lise-Marie Lacroix; Fabien Delpech; Céline Nayral; Sébastien Lachaize; Bruno Chaudret
Journal:  Interface Focus       Date:  2013-06-06       Impact factor: 3.906

3.  RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.

Authors:  Dan Shan; Jason Li; Ping Cai; Preethy Prasad; Franky Liu; Andrew Michael Rauth; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

4.  The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice.

Authors:  Sjoerd Hak; Zuzana Garaiova; Linda Therese Olsen; Asbjørn Magne Nilsen; Catharina de Lange Davies
Journal:  Pharm Res       Date:  2014-10-28       Impact factor: 4.200

Review 5.  Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles.

Authors:  Randall Toy; Pubudu M Peiris; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Nanomedicine (Lond)       Date:  2014-01       Impact factor: 5.307

Review 6.  Self-assembling peptide-based building blocks in medical applications.

Authors:  Handan Acar; Samanvaya Srivastava; Eun Ji Chung; Mathew R Schnorenberg; John C Barrett; James L LaBelle; Matthew Tirrell
Journal:  Adv Drug Deliv Rev       Date:  2016-08-14       Impact factor: 15.470

7.  Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

Authors:  Blaine J Zern; Ann-Marie Chacko; Jin Liu; Colin F Greineder; Eric R Blankemeyer; Ravi Radhakrishnan; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2013-02-08       Impact factor: 15.881

8.  Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging.

Authors:  Peter A Jarzyna; Lisette H Deddens; Benjamin H Kann; Sarayu Ramachandran; Claudia Calcagno; Wei Chen; Anita Gianella; Rick M Dijkhuizen; Arjan W Griffioen; Zahi A Fayad; Willem J M Mulder
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

9.  The nano-plasma interface: Implications of the protein corona.

Authors:  Joy Wolfram; Yong Yang; Jianliang Shen; Asad Moten; Chunying Chen; Haifa Shen; Mauro Ferrari; Yuliang Zhao
Journal:  Colloids Surf B Biointerfaces       Date:  2014-03-02       Impact factor: 5.268

10.  Challenges and opportunities in the advancement of nanomedicines.

Authors:  Alexander Wei; Jonathan G Mehtala; Anil K Patri
Journal:  J Control Release       Date:  2012-10-12       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.